| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |